<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>3 Low-Volatility Stocks We Find Risky — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">3 Low-Volatility Stocks We Find Risky</h2>
    <div class="badge">2025-09-15T04:41:13+00:00</div>
    <ul>
      <li>- Incremental sales over the last five years were less profitable as its 8.6% annual earnings per share growth lagged its revenue gains Intercontinental Exchange’s stock price of $175.99 implies a valuation ratio of 23.9</li>
<li>- Disappointing same-store sales over the past two years show customers aren’t responding well to its menu offerings and dining experience - Projected sales growth of 4.8% for the next 12 months suggests sluggish demand</li>
<li>Brands in 2016.</li>
<li>- Below-average returns on capital indicate management struggled to find compelling investment opportunities At $10 per share, Amneal trades at 14.2x forward P/E.</li>
<li>High-Quality Stocks for All Market Conditions Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.</li>
<li>Amneal (AMRX) Rolling One-Year Beta: 0.68 Founded in 2002 and growing into one of America&#x27;s largest generic drug producers, Amneal Pharmaceuticals (NASDAQ:AMRX) develops, manufactures, and distributes generic medicines</li>
<li>Intercontinental Exchange (ICE) Rolling One-Year Beta: 0.56 Starting as an energy trading platform in 2000 before acquiring the iconic New York Stock Exchange in 2013, Intercontinental Exchange (NYSE:ICE) operates global</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=3 Low-Volatility Stocks We Find Risky\n• - Incremental sales over the last five years were less profitable as its 8.6% annual earnings per share growth lagged its revenue gains Intercontinental Exchange’s stock price of $175.99 implies a valuation ratio of 23.9\n• - Disappointing same-store sales over the past two years show customers aren’t responding well to its menu offerings and dining experience - Projected sales growth of 4.8% for the next 12 months suggests sluggish demand\n• Brands in 2016.\n• - Below-average returns on capital indicate management struggled to find compelling investment opportunities At $10 per share, Amneal trades at 14.2x forward P/E.\n• High-Quality Stocks for All Market Conditions Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.\n• Amneal (AMRX) Rolling One-Year Beta: 0.68 Founded in 2002 and growing into one of America&#x27;s largest generic drug producers, Amneal Pharmaceuticals (NASDAQ:AMRX) develops, manufactures, and distributes generic medicines\n• Intercontinental Exchange (ICE) Rolling One-Year Beta: 0.56 Starting as an energy trading platform in 2000 before acquiring the iconic New York Stock Exchange in 2013, Intercontinental Exchange (NYSE:ICE) operates global" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/3-low-volatility-stocks-risky-044113184.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>